SeaLink Capital Partners

SCP sources through direct founder relationships and deep sector networks in Indian healthcare and technology, with a stated preference for entrepreneurs who have high integrity standards. Testimonials from portfolio company leaders indicate the firm builds relationships over extended pre-investment periods, and its active post-investment board involvement generates referral flow from existing founders and industry executives.

SCP targets growth-stage companies with strong competitive differentiation and proven business models, not seed or early-stage startups. The firm's known investments — Surya Hospitals, Global Dental Services, THB, Ki Mobility, and the prior NephroPlus position — are all established operating businesses with material revenue and market presence at the time of investment.

SCP's model is unusual for a growth-equity firm: it embeds partners into board governance and actively drives operational initiatives. At NephroPlus, SCP led work on employee compensation structures, ESOP allocation, pricing strategy, pharmacy revenue improvements, and inorganic acquisitions. At Surya Hospitals, founder Dr. B.S. Avasthi noted the firm is "very actively involved in our operations" and that "debates and discussions" helped improve hospital performance — a level of engagement more typical of control buyout firms than minority growth investors.